Medicamen Biotech has informed that it attached disclosure dated March 08, 2024 in Form-D pursuant to Regulation 7(3) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 with respect to intimation received from Geetika Madan, immediate relative of Rajesh Madan, Chief Executive Officer for sale of 5531 Equity Shares from the open market. This intimation is in compliance with Regulation 7(3) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.